Consent Issues in the Management of Cerebrovascular Diseases, A Position Paper of the American Academy of Neurology Ethics and Humanities Subcommittee
Neurol 53:9-11, , 1999
Is There Still a Role for Intravenous Heparin in Acute Stroke? No
Arch Neurol 56:1160-1162, Sandercock,P., 1999
Management Issues for Women with Epilepsy,A Review of the Literature
Neurol 51:949-956, Zahn,C.A.,et al, 1998
Further Evolution Toward Effective Therapy for Acute Ischemic Stroke
JAMA 279:1298-1303, 13041998., Fisher,M.&Bogousslavsky,J., 1998
Consensus Against Both Endarterectomy and Routine Screening for Asymptomatic Carotid Artery Stenosis
Arch Neurol 54:25-28, 231997., Perry,J.R.,et al, 1997
Measuring Quality of Care in Neurology
Arch Neurol 54:1329-1332, 13271997., Ringel,S.P.&Vickrey,B.G., 1997
Implementation of an Acute Stroke Program Decreases Hospitalization Costs and Length of Stay
Stroke 27:1040-1043, Wentworth,D.A.&Atkinson,R.P., 1996
Apolipoprotein E Genotyping in Alzheimer's Disease
Lancet 347:1091-1095, Tanzi,R.,et al, 1996
US NEurologists:Attitudes on the US Health Care System
Neurol 47:279-287, Ringel,S.P.,et al, 1996
Evidence-Based Medicine, Critical Pathways, Practice Guidelines, & Managed Care:Prevention & Care of Stroke
Arch Neurol 53:867-871, Ringel,S.P.&Hughes,R.L., 1996
Outcome Research in Neurology:Incorporating Health-Related Quality of Life
Ann Neurol 37:141-142, Devinsky,O., 1995
Outcome Assessment for Epilepsy Surgery:The Impact of Measuring Health-Related Quality of Life
Ann Neurol 37:158-166, 1411995., Vickrey,B.G.,et al, 1995
Recurrent Stroke and Thrombo-Occlusive Events in the Antiphospholipid Syndrome
Ann Neurol 38:119-124, Levine,S.R.,et al, 1995
Research Involv Subj with Dementia & Other Cognitive Impairments:NIH, & Ethical Considerations
Neurol 45:1777-1778, Wichman,A.&Sandler,A.L., 1995
Inclusion Body Myositis and Myopathies
Ann Neurol 38:705-713, Griggs,R.C.,et al, 1995
Betaseron for Multiple Sclerosis:Implications for Therapeutics
Arch Neurol 51:125-128, Rudick,R., 1994
Stroke:The Way Things Really Are
Stroke 25:1290-1294, Scheinberg,P., 1994
Effect of a Stroke Protocol on Hospital Costs of Stroke Patients
Neurol 44:1961-1964, Bowen,J.&Yaste,C., 1994
Evolving Toward Effective Therapy for Acute Ischemic Stroke
JAMA 270:360-364, Fisher,M.&Bogousslavsky,J., 1993
The Results of Clinical Trials in Stroke Rehabilitation Research
Arch Neurol 50:37-44, ottenbacher,K.J.&Jannell,S., 1993
Vascular Dementia:Diagnostic Criteria for Research Studies, Report of the NINDS-AIREN Intern'l Workshop
Neurol 43:250-260, Romas,G.C.,et al, 1993
Use of Twin Cohorts for Research in Alzheimer's Disease
Neurol 43:261-267, Breitner,J.C.S.,et al, 1993
The Use of Fetal Tissue in Research on Parkinson's Disease
NEJM 327:1591-1592, Kassirer,J.P.&Angell,M., 1992
Screening for Dementia and Investigating Its Causes
Ann Int Med 115:122-132, Siu,A.L., 1991
Cerebrovascular and Neurologic Disease Associated with Antiphospholipid Antibodies:48 Cases
Neurol 40:1181-1189, Levine,S.R.,et al, 1990
Cerebrovascular Ischemia Associated with Lupus Anticoagulant
Stroke 18:257-263, Levine,S.R.&Welch,K.M.A., 1987
The Spectrum of Neurol Dis Assoc with Antiphospholipid Antibd, Lupus Anticoag & Anticardiolipin Antibd
Arch Neurol 44:876-883, Levin,S.R.&Welch,K.M.A., 1987
Iatrogenic Cerebral Amyloid Angiopathy after Cardiac Surgery, Two Case Reports
Neurol 106:e214819, Brunet de Courssou,J-B.,et al, 2026
Clinical Manifestations of Primary CNS T-Cell Lymphoma, Retrospective Study of Histopathologic, Molecular, and Neuroimaging Fetures
Neurol 106:e24744, Muller,K.J.,et al, 2026
Glucagon-like Peptide-1 Receptor Agonists and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy
Neurol 106:e214864, Dhivagaran,T.,et al, 2026
Endovascular Venous Sinus Stenting versus CSF Shunting for Idiopathic Intracranial Hypertssion:Nationwide Real-World Outcomes
AJNR 47:1238-1243, Chen,H.,et al, 2026
Cerebral Amyloid Angiopathy
NEJM 394:1836-1845, Greenberg,S.M., 2026
Endovascular Therapy for Medium-Vessel Occlusion Stroke - Narrowing the Target Population
NEJM 394:1955-1957,1894, Ospel,J.M. & Hill, M.D., 2026
A 55-Year-Old Man with Rapidly Progressive Weakness and Numbness
Neurol 106:e218063, Li,X.,et al, 2026
Safety and Outcomes of Dibigatran Reversal with Idarucizumab Before IV Thrombolysis in Patients with Acute Ischemic Stroke
Neurol 106:e218012, Saflund,M.,et al, 2026
Inflammatory Myopathies
NEJM 394:1925-1938, AllenBach,Y. & Benveniste,O., 2026
Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After IschemicStroke, The OPTION Randomized Clinical Trial
JAMA doi:10.1001/JAMA.2026.0210, Ma,G.,et al, 2026
A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion
NEJM 394:442-450, Ryan,S.J.,et al, 2026
Mucormycosis
NEJM 394:684-698, Kontoyiannia,D.P. & Walsh, T.J., 2026
Secondary Prevention after Ischemic Stroke
NEJM 394:784-792, Frie,K.L.,et al, 2026
Neurosyphilis with Abnormal in the Bilateral Pons and Multifocal Cranial Nerve Enhancement
Ann Neurol 99:283-284, Zhang,Y.,et al, 2026
Restless Legs Syndrome, A Review
JAMA 335:703-714, Winkelmen,J.W. & Wipper, B., 2026
Unilateral Primary Angiitis of the Central Nervous System: A Rare and Under-Recognized Entity
AJNR 47:589-595, Rai,P.,et al, 2026
Niemann-Pick Type C Disease
www.UpToDate.com, Nov, Schiffmann, R., 2026
Polymyalgia Rheumatica
NEJM 394:1097-1109, Dejaco,C.,et al, 2026
Progressive Quadriparesis and Falls in a 66-Year-Old Man With Longstanding Human Immunodeficiency Virus
Neurol 106:e214621, Ong,B.A. & Carlson,A.K., 2026
Intravenous Thrombolysis Use in the Late Time Window Before Interhospital Transfer for Thrombectomy
JAMA Neurol 83:60-67, Seners,P.,et al, 2026
Medical Management and Revascularization for Asymptomatic Carotid Stenosis
NEJM 394:219-231 296, Hrott,T.G.,et al, 2026
Systematic Genetic Assessment in Young Patients with Cryptogenic Stroke: The ES-EASY Project
Stroke 57:148-156, Mania-Paris,L.,et al, 2026
Peripheral Neuropathy, A Review
JAMA 335:255-266, Mauermann,M.L. & Staff,N.P., 2026